Practice and research on the whole course medication management mode led by pharmacists in rheumatic immune diseases
- VernacularTitle:以药师为主导的全程化用药管理模式在风湿免疫性疾病中的实践研究
- Author:
Jianmin LIU
1
;
Yikai LIN
1
;
Hegui HUANG
1
;
Ye HUANG
1
,
2
;
Qiuyu FAN
3
;
Huiqin YANG
3
;
Shaohui ZHANG
1
Author Information
1. Dept. of Pharmacy，Wuhan No.1 Hospital，Wuhan 430022，China
2. School of Pharmacy，Hubei University of Science and Technology，Hubei Xianning 437100，China
3. Dept. of Rheumatology and Immunology，Wuhan No.1 Hospital，Wuhan 430022，China
- Publication Type:Journal Article
- Keywords:
individual pharmacist;
rheumatic immune disease;
whole course medication management;
specialist clinical
- From:
China Pharmacy
2022;33(17):2147-2151
- CountryChina
- Language:Chinese
-
Abstract:
OBJECT IVE To evaluate the application effect of the whole cour se medication management mode led by pharmacists in rheumatic immune diseases. METHODS A total of 122 patients treated with tacrolimus or cyclosporine in the department of rheumatology and immunology of Wuhan No. 1 Hospital from 2018 to 2020 were selected as the study subjects. Among them ，44 cases in the control group were under the traditional supervision mode ；78 patients in the observation group adopted the whole course medication management mode led by pharmacists ，that was ，individual pharmacists and specialist clinical pharmacists cooperated and led ，and not only participated in the whole process of drug treatment but also involved in the whole process of therapeutic drug monitoring （TDM）. On the basis of the control group ，the division of labor and cooperation among medical，pharmaceutical and nursing parties were strengthened ，and the homogeneous supervision was carried out for the outpatients and inpatients from admission to discharge . The daily dose of medication ，the rate of reaching the standard of blood drug concentration ，the incidence of problematic samples （the sample was calculated by the number of times ），the average hospitalization days ，the re-admission rate within 6 months after discharge ，the medication compliance score and the patient ’s satisfaction rate were compared between the two groups. RESULTS In the control group ，53 times of TDM were performed ， including 18 times of tacrolimus monitoring and 35 times of cyclosporine monitoring ；in the observation group ，123 timesof TDM were performed ，including 55 times of tacrolimus monitoring and 68 times of cyclosporine monitoring. The daily dose of tacrolimus ，the daily dose of cyclosporine ，the rate of reaching the standard of cyclosporine blood drugconcentration，the inc idence of problematic samples ，the rate of re-admission within 6 months after discharge ， the medication compliance score and the patient ’s satisfaction rate in the observation group were significantly better than those in the control group （P＜0.05）. CONCLUSIONS It can effectively improve the effect of the quality of pharmaceutical care to implement whole course and homogeneous medication management led by pharmacists and provide precise drug guidance for patients with rheumatic and immune diseases.
